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Mitogen activated protein kinase
Free radicalInterferon-gamma (Ifnγ), a known immunomodulatory cytokine, regulates cell proliferation and survival. In this
study, the mechanisms leading to the selective susceptibility of some tumor cells to Ifnγwere deciphered. Seven
different mouse tumor cell lines tested demonstrated upregulation of MHC class I to variable extents with Ifnγ;
however, only the cell lines, H6 hepatoma and L929 ﬁbrosarcoma, that produce higher amounts of nitric oxide
(NO) and reactive oxygen species (ROS) are sensitive to Ifnγ-induced cell death. NO inhibitors greatly reduce
Ifnγ-induced ROS; however, ROS inhibitors did not affect the levels of Ifnγ-induced NO, demonstrating that
NO regulates ROS. Consequently, NO inhibitors are more effective, compared to ROS inhibitors, in reducing
Ifnγ-induced cell death. Further analysis revealed that Ifnγ induces peroxynitrite and 3-nitrotyrosine amounts
and a peroxynitrite scavenger, FeTPPS, reduces cell death. Ifnγ treatment induces the phosphorylation of c-jun
N-terminal kinase (Jnk) in H6 and L929 but not CT26, a colon carcinoma cell line, which is resistant to Ifnγ-
mediated death. Jnk activation downstream to NO leads to induction of ROS, peroxynitrite and cell death in re-
sponse to Ifnγ. Importantly, three cell lines tested, i.e. CT26, EL4 and Neuro2a, that are resistant to cell death
with Ifnγ alone become sensitive to the combination of Ifnγ and NO donor or ROS inducer in a peroxynitrite-
dependent manner. Overall, this study delineates the key roles of NO as the initiator and Jnk, ROS, and
peroxynitrite as the effectors during Ifnγ-mediated cell death. The implications of these ﬁndings in the Ifnγ-
mediated treatment of malignancies are discussed.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
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i).cellular responses, including inﬂammation, cell growth and survival.
Ifnγ binds to its cell surface receptor and signals via the Janus kinase 1
(Jak1)–signal transducer and activator of transcription 1 (Stat1) path-
way to modulate the expression of several genes involved in host de-
fense. Importantly, Ifnγ has been used to treat people suffering from
chronic granulomatous disease, autoimmune disease etc. [1–4].
Among the plethora of functions mediated by Ifnγ, its ability to modu-
late cell growth and survival is an important area of study. Ifnγ plays a
pro-tumorigenic role in some types of cells e.g. melanoma cells [5,6];
however, thepro-apoptotic role of Ifnγhas been demonstrated in sever-
al cells and is likely to be physiologically relevant: First, in amodel of ex-
perimental autoimmune encephalomyelitis, Ifnγ−/− mice accumulate
more numbers of activated T cells compared to wild type mice [7]. Sec-
ond, Ifnγ production by NK cells reduces hepatocyte cell proliferation
during partial hepatectomy and involves Stat1, interferon regulated fac-
tor 1 (Irf1) and p21 cell cycle inhibitor [8]. Third, mice lacking IfnγR or
Stat1 demonstrate enhanced methylcholanthrene-induced tumors [9].
There are multiple mechanisms by which Ifnγ reduces cell cycling and
induces apoptosis [2,10]. Ifnγ induces the cell cycle inhibitors, p21 and
p27, which results in the hypo-phosphorylation of the tumor
Fig. 1. Ifnγ treatment leads to cell death in some tumor cell lines. A panel of cancer cell
lines: H6 (hepatoma), EL4 (thymoma), Neuro2A (neuroblastoma), L929 (ﬁbrosarcoma),
CT26 (colon carcinoma), TA3 (mammary carcinoma) and WEHI-3 (myelomonocytic leu-
kemia) were treated with different concentrations of Ifnγ for 48 h and cell proliferation
(A) as well as cell viability (B) were assayed for the same. The data are represented as
mean ± SE from three independent experiments. The signiﬁcance is represented as *, Δ,
τ, θ, Κ and ε for H6, L929, CT26, Neuro2A, TA3 and WEHI cells respectively.
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transcription factors; consequently, there is reduction in the activation
of genes (e.g. c-Myc) involved in cell cycle progression. In addition,
Ifnγ induces Irf1, a tumor suppressor, and decreases cell survival by re-
ducing the amounts of Bcl2, increasing Bak amounts, reducing mito-
chondrial function, enhancing the release of Cytochrome c and
activation of Caspases, resulting in apoptosis [11].
Ifnγ has been used to treat several malignancies in the clinical set-
ting; however, the responses have been mixed. In fact, not all tumor
cell types are known to respond to the cytotoxic/cytostatic effects of
Ifnγ. It is possible that the differential reports on the roles of Ifnγ during
tumor progression in vivo may be dependent on the cellular and com-
plex microenvironment present etc. [3,6]. Also, the non-responsiveness
could be explained, in part, due to differential expression of the receptor
subunits or downstream signalingmolecules to Ifnγ. For example, T cells
express much lower amounts of IfnγR2 when compared to myeloid
cells; consequently, myeloid cells respond by producing Irf1 that results
in apoptosis with Ifnγ [12]. In fact, ﬁbrosarcoma cell lines expressing a
dominant negative IfnγR1 grow better as tumors and resist rejection
in syngeneic mice [13]. Both these studies exemplify the roles of proxi-
mal signalingmolecules such as IfnγR, Stat1 and Irf1 during Ifnγ induced
apoptosis in tumor cells. However, the induction of Stat1 and Irf1 alone
does not fully explain the differential sensitivity of tumor cell types to
Ifnγ induced cell death [14]. These observations led us to investigateFig. 2. Ifnγ induces nitrosative and oxidative responses inH6 and L929, but not CT26, cells. H6 ce
for indicated time points and analysis of speciﬁc mRNA levels (A), intracellular pStat1 (B), cel
intracellular ROS (F) amounts were performed. The data are represented as mean ± SE from tthe molecular differences between Ifnγ induced cell death sensitive
and resistant tumor cell types in vitro.
Previous studies have revealed the importance of intracellular reac-
tive oxygen species (ROS) and reactive nitrogen intermediates (RNI)
during Ifnγmediated responses [15]. ROS andRNImediate different sig-
naling pathways to regulate cell survival. Under normal physiological
conditions, the function of redox sensitive signaling proteins remains
unaffected because of the homeostatic balance maintained between
the generation and elimination of ROS/RNI [16]. Usually low to moder-
ate concentrations of ROS/RNI are associated with cell proliferation,
whereas higher concentrations of ROS/RNI disturb the redox homeosta-
sis, activate stress related signaling pathways and culminate in cellular
injury and/or disease in the host [17,18]. Ifnγ is a potent inducer of nitric
oxide synthase 2 (Nos2) in a variety of leukocytes that converts L-
arginine into L-citrulline and NO [19]. Interestingly, mouse, but not
human, macrophages are highly responsive to inﬂammatory signals
with respect to the induction of Nos2 probably due to epigenetic modi-
ﬁcations [20]. Once produced, NO can further combine with superoxide
(O2−) to form unstable yet potent oxidants including peroxynitrite
(ONOO−) that reduces tumor growth and prevents metastasis [19].
In primary cultured hepatocytes, Ifnγ induces high amounts of ROS
which, in combination with ER stress, induces apoptosis [21]. In fact,
lowering of ER stress leads to reduction in Caspase activation without
affecting the amounts of Irf1 and ROS [22]. Studies on a hepatoma cell
line H6 have also demonstrated the crucial roles of ROS and RNI inmod-
ulating expression of a subset of Ifnγ responsive genes that enhance
growth suppression [15]. In the present study, we identify that those
tumor cells that produce high amounts of RNI and ROS in response to
Ifnγ are the ones that undergo growth arrest and apoptosis in vitro. Im-
portantly, the roles of RNI and ROS as well as their interrelationship
were studied. This study is important as better understanding of signal-
ingmolecules that govern sensitivity or resistance of a tumor cell type to
Ifnγ induced cell growth suppression and apoptosis may lead to strate-
gies that broaden and/or enhance the efﬁcacy of Ifnγ as an anti-tumor
molecule.
2. Materials and methods
2.1. Reagents
Ifnγ (recombinant mouse Ifnγ expressed in Escherichia coli) from
PeproTech, Israel was titrated and used at indicated doses (U/ml).
Culture supernatants from hybridomas secreting monoclonal anti-
bodies were used to detect MHC class I (MHC-I): 11-4-1 (TIB 95;
anti-Kk, p, q, r) and 34-2-12S (HB-87; anti-Dd, α3 domain) as
previously described [23]. FITC-labeled goat anti-mouse and goat
anti-rabbit secondary antibodies were obtained from Jackson
ImmunoResearch Laboratories, West Grove, PA, USA. NG-methyl-L-
arginine (LNMA), aminoguanidine (AG), PEG–catalase (PEG–CAT),
PEG–superoxide dismutase (PEG–SOD), S-Nitroso-N-acetyl-DL-penicilla-
mine (SNAP), tert-butyl hydroperoxide (t-BHP), 4, 5-diaminoﬂuorescein
diacetate (DAF2DA), dihydrorhodamine 123 (DHR123), 5,5′,6,6′-
tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1),
SP600125 (Jnki), and lipopolysaccharide (LPS) were obtained from
Sigma-Aldrich (St. Louis, MO, USA). 2′, 7′-Dichloroﬂuorescin diacetate
(DCFDA), 5,10,15,20-Tetrakis(4-sulfonatophenyl) porphyrinato iron
(III), chloride (FeTPPS), anti-p47phox, anti-phospho-Stat1, anti-Nos2,
anti-phospho-Jnk, anti-cleaved Caspase-3 and anti-cleaved Caspase-9
antibodies were purchased from Merck-Millipore (Darmstadt,
Germany). 3-Nitrotyrosine (3-NT) was purchased from Santa Cruzlls were treatedwith 25U/ml Ifnγ and L929 and CT26 cells were treatedwith 50U/ml Ifnγ
l surface MHC-I (Kk and Dd) (C), intracellular Nos2 (D), nitrite in the supernatant (E) and
hree independent experiments.
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tained from Invitrogen (Carlsbad, CA, USA).
2.2. Cell culture
H6 cells (hepatoma, H-2a) were cultured in RPMI 1640medium con-
taining 25 mM HEPES (Sigma) and 5% heat-inactivated FCS (Life Tech-
nologies, NY, USA). EL4 (thymoma), L929 (ﬁbrosarcoma), CT26 (colon
carcinoma) and WEHI-3 (myelomonocytic leukemia) cells were main-
tained in RPMI 1640 medium and Neuro2A (neuroblastoma) and TA3
(mammary adenocarcinoma) cells were maintained in Dulbecco's mod-
iﬁed minimal essential medium (DMEM) including high glucose
(Sigma); both media contain 10% FCS. Media were supplemented with
5 μMβ-mercaptoethanol (Sigma), 100 μg/ml penicillin, 250 μg/ml strep-
tomycin, 50 μg/ml gentamycin (HiMedia Labs, Mumbai, India) and
2 mM glutamine (Life Technologies, Carlsbad, CA, USA). Thioglycollate-
elicited peritoneal exudate cells (TG-PECs) were isolated from the
mouse peritoneum in RPMI media four days post injection of 4%
thioglycollate. All cell lines were maintained at 37 °C in a humidiﬁed in-
cubator (Sanyo, UK) under an atmosphere of 95% air and 5% CO2.
2.3. Trypan blue exclusion assay
To assay for cell viability, logarithmically growing cells were plated
at a density of ~104 cells/well in a 96 well plate. Subsequently, cells
were treated with Ifnγ, SNAP or t-BHP either alone or in the presence
of RNI/ROS/Jnk inhibitors for 48 h. Adherent cells were harvested by
adding 100 μl of 0.5% Trypsin–EDTA (Sigma) per well. An equal volume
of 0.4% Trypan blue was added and the number of viable cells was
counted in a hemocytometer.
2.4. Analysis of MHC-I surface expression
The expression of MHC-I was determined by ﬂow cytometry, as de-
scribed previously [30]. Cells were treated with Ifnγ in the presence or
absence of different inhibitors for different time points or 48 h. After
these treatments, ~5 × 105 cells were centrifuged and incubated with
optimal amounts of primary monoclonal antibodies to MHC-I for
30 min at 4 °C. Cells were washed and incubated with appropriate
amounts of secondary antibodies for 30 min at 4 °C. Subsequently,
cells werewashedwithwash buffer and ﬁxedwith 0.5ml of 1% parafor-
maldehyde at 4 °C. Analysis was performed on a FACSCalibur ﬂow
cytometer (Becton Dickinson, Sunnyvale, CA) and Cell Quest software
(BD Biosciences, Franklin Lakes, NJ) was used for acquisition. The data
was analyzed using WinMDI 2.9 software.
2.5. Nitrite measurement
The production of NO was estimated from the accumulation of ni-
trite, the metabolic end product of NO metabolism, in the medium
using the Greiss reagent as described previously [24]. Brieﬂy, 50 μl of
the cell free supernatant and 100 μl of Greiss reagent (a mixture of 1%
(w/v) Sulfanilamide and 0.1% (w/v) naphthylethylenediamine
dihydrochloride prepared in 2.5% phosphoric acid) were mixed and
subsequently, absorbance was measured at 550 nm using a microtiter
plate reader (Molecular Devices, Downingtown, PA, USA). The amount
of nitrite in the supernatants was calculated using a standard curve per-
formed using 0.2–208 μM of sodium nitrite.Fig. 3.NOmediates ROS induction and cell death in response to Ifnγ. H6 (left) and L929 (right)
AG; 250 μMeach) or ROS inhibitors (PEG–CAT at 100 U/ml and PEG–SOD at 50 U/ml) andwere
Further, analysis of cell surfaceMHC-I (Kk) levels (A), nitrite in the supernatant (B), intracellular
three independent experiments. The signiﬁcance is represented as * and # when individual co2.6. RNA extraction and semi-quantitative RT-PCR
Total RNA was extracted from ~1 × 106 cells using 1 ml of TRI re-
agent (Sigma) according to the manufacturer's instructions. Brieﬂy,
total RNA (2 μg) was reverse transcribed using 50 U of MMLV-Reverse
transcriptase and oligo dT(12–18mer) primer (Fermentas, Canada) in a
40 μl volume. cDNA (2 μl) was used as template for PCR ampliﬁcation
in buffer containing 0.4 μM of each primer, 200 μM of dNTP mix and
0.25 U of Taq polymerase (Bangalore Genei, India). Gene speciﬁc PCR
ampliﬁcation was carried out at speciﬁc temperature and cycles using
speciﬁc sets of primers (Supplementary Table 1). The ampliﬁed PCR
products were fractionated on 1.5% agarose gels and visualized by
ethidium bromide staining.
2.7. Detection of intracellular ROS,mitochondrial ROS and peroxynitrite levels
The production of ROS and peroxynitrite was measured using the
speciﬁc cell permeable probes, DCFDA and DHR123. After entering
cells, these probes are deacetylated by intracellular esterases and upon
oxidation by excess ROS and peroxynitrite are converted to highly ﬂuo-
rescent compounds, DCF and rhodamine, respectively. Cells were
washed and incubated with 10 μM of dye with RPMI medium without
FCS for 20min at 37 °C in the dark. Afterwashing twicewith PBS, the in-
tensity of DCFDA and DHR123 ﬂuorescence was determined by using
the ﬂow cytometer, with an excitation wavelength of 480 nm and an
emission wavelength of 530 nm. The Mean Fluorescence Intensity
(MFI) values were obtained after gating on the live cell population
using side scatter and forward scatter plots. Also, in some experiments
(Figs. 5 and 7), cells treated in black-well plates were stained with
DCFDA, DHR123 and MitoSox red and the individual ﬂuorescence was
measured using a ﬂuorescence plate reader (Inﬁnite 200 Pro, Tecan,
Switzerland).MitoSox redwas used to stain live cells tomeasure the ex-
tent of mitochondrial superoxide generated post speciﬁc treatment of
cells. The ﬂuorescence from the dyeswas normalized to amount of ﬂuo-
rescence of Hoechst 33342 (100 ng/ml) staining in the samples as
assessed by the excitation and emission at 350 nm and 470 nm respec-
tively. The changes in the total ROS, peroxynitrite and mitochondrial
ROSwere represented as fold changewith respect to untreated controls,
as described previously [25].
2.8. Assessment of mitochondrial membrane potential
The loss of mitochondrial membrane potential (MMP, ΔΨm) was
measured by the use of JC-1, a cationic dye. JC-1 emits green ﬂuores-
cence when it exists in monomeric form in the cytosol but emits red
ﬂuorescence when it accumulates as aggregates in the mitochondria
in normal cells. In apoptotic/necrotic cells, the ΔΨm collapse halts the
mitochondrial accumulation of JC-1 and maintains it in the cytosol,
thereby, emitting primarily green ﬂuorescence. ~5 × 105 cells were
treated with Ifnγ for various time points and then incubated with
2.5 μg/ml JC-1 at 37 °C for 15 min in the dark. Fluorescence intensities
were detected by ﬂow cytometry and analyzed using WinMDI 2.9
software.
2.9. Detection of apoptosis
Cells were differentiated from viable or necrotic ones by combined
application of Annexin V-FITC and PI, using an Apoptosis Detection Kit
(Merck-Millipore, Darmstadt, Germany). Brieﬂy, cells (~106) werecells were incubated either alone or pre-treated for 1 h with speciﬁc NO inhibitors (LNMA,
cultured in the presence or absence of 25 and 50U/ml Ifnγ treatment respectively for 48 h.
ROS (C) and cell viability (D)were performed. Thedata are represented asmean±SE from
nditions were compared to cells alone and Ifnγ alone controls respectively.
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buffer (10 mMHEPES/NaOH, 0.14 M NaCl, 2.5 mM CaCl2, pH 7.5). Sam-
ples were incubated with 0.5 μg/ml Annexin V-FITC and 2 μg/ml PI for
10 min at room temperature in the dark. Data acquisition was per-
formed in ﬂow cytometer using CellQuest software. Data were analyzed
by the software (WinMDI 2.9).
2.10. Proliferation assay
Cell proliferation was assessed using a colorimetric bromode-
oxyuridine (BrdU) ELISA kit (Merck-Millipore, Darmstadt, Germany).
Cells (~104) were cultured in BrdU-containing medium for 24 h,
washed and incubated with indicated concentrations of Ifnγ for 48 h
or different time points. The plates were centrifuged and supernatants
were discarded. Cells were incubated with 100 μl of ﬁxative solution
for 30 min followed by incubation with a mouse monoclonal anti-
BrdU for 1 h. After washing, horseradish peroxidase-conjugated goat
anti-mouse was added and incubated for 30 min. After several washes,
the chromogenic substrate [3,3′,5,5′-tetramethylbenzidine (TMB)] was
added and the intensity of the colored reaction product, which is pro-
portional to the amount of BrdU incorporated into the cells, was read
with a spectrophotometer at 450 nm. The percentage of BrdU incorpo-
ration was established by applying the formula, % proliferation = (ex-
perimental O.D − background O.D) / control O.D × 100. O.D from
untreated control cells was considered as 100% BrdU incorporated
after subtracting the background (O.D for unlabeled cells). Control O.D
refers to O.D of untreated cells after subtracting the background
(O.D for unlabeled cells) and is considered as 100% BrdU incorporation.
2.11. Detection and estimation of speciﬁc intracellular proteins
After appropriate treatments, cells were ﬁxed with 4% paraformal-
dehyde for 15 min, and permeabilized with 0.1% Triton X-100 for
10 min. Cells were then washed, blocked with blocking buffer (5% FCS
in PBS) for 30 min and incubated with speciﬁc concentrations of
pStat1, Nos2, p47Phox, pJnk, cleaved Caspase 3, cleaved Caspase 9 anti-
bodies and 3-nitrotyrosinediluted in blocking buffer for 45min at 37 °C.
Cells were again washed with permeabilization buffer, labeled with ap-
propriate dilution of secondary antibodies for 30min at 37 °C in thedark
and analyzed by ﬂow cytometry at 525 nm for cleaved Caspase 3 and
Caspase 9. For the estimation of pStat1, Nos2, p47Phox, pJnk and 3-NT
amounts, cells in black-well plates were stainedwith speciﬁc antibodies
as described above and the ﬂuorescence was measured using a ﬂuores-
cence plate reader. The ﬂuorescence from the dyes was normalized to
amount of ﬂuorescence of Hoechst staining in the samples. The changes
in theprotein amounts upon treatmentwere represented as fold change
with respect to untreated controls, as described previously [25].
2.12. Confocal microscopy
Cellswere seeded on 25-mm roundglass coverslips and treatedwith
Ifnγ, washedwith PBS and stained for 20minwith 10 μMDCFDA, 10 μM
DAF2DA and 10 μM DHR123 at 37 °C in the dark. Coverslips were
washed thoroughly and stained with Hoechst 33342 (0.5 μg/ml;
Sigma) to visualize nuclei. Coverslips were mounted cell-side down on
glass slides with 5 μl of ﬂuorescence-free glycerol-based mounting me-
dium containing 0.25% DABCO antifade reagent. Images were viewedFig. 4. Peroxynitrite is a key effector of Ifnγ induced cell death. Kinetic analysis of the intracellu
indicated time points (A). H6 (left) and L929 (right) cells were treatedwith 25 and 50U/ml Ifnγ
and L929 (right) cells were incubated either alone or preincubated for 1 hwith speciﬁc NO inhib
at 50 U/ml) and cultured in the presence or absence of 25 and 50U/ml Ifnγ respectively for 48 h
alone or pre-treated for 1 h with 50 μM FeTPPS followed by treatment with 25 and 50 U/ml Ifn
levels and cell viability (D). The data are represented asmean± SE from three independent exp
pared to cells alone and Ifnγ alone controls respectively.under a 63×/1.4 oil immersion objective ﬁtted in a Zeiss LSM 510
META confocal microscope.
2.13. Statistical analyses
Thedata is presented as themean± standard error (SE). Differences
between the groups were examined for statistical signiﬁcance
(GraphPad Prism 5) using one way analysis of variance by ANOVA and
p values b0.05, 0.01 and 0.001 are represented as *, ** and *** respective-
ly in comparison to untreated controls. In case, other controlswere used
for comparison, the usage of additional symbols is mentioned in the ﬁg-
ure legends.
3. Results
3.1. Tumor cell lines differentially respond to Ifnγ induced cell death
Initially, the effect of Ifnγ on cell viability and proliferation of differ-
ent tumor cell lines was studied. The response of different cells to Ifnγ
was studied using induction of MHC-I as the readout because Ifnγ is a
potent inducer ofMHCmolecules [26]. Most of the tumor cell lines test-
ed in this study expressed undetectable or very low levels of MHC-I and
Ifnγ treatment led to enhanced but variable expression of MHC-I in dif-
ferent cell lines. The most profound induction in cell surface levels of
MHC-I in response to Ifnγ was observed on the H6 hepatoma and
L929 ﬁbroblast cell lines (~9–12 fold) whereas in rest of them the in-
crease in MHC-I ranged from ~1.5–5 fold (Supplementary Fig. 1A). Of
the seven cell lines tested, only H6 and L929 showed reduced viability
coupled with enhanced growth suppression in a dose dependent man-
ner. TheWEHI-3 cell line wasmildly sensitive at the highest concentra-
tion, whereas, other cells (EL4, Neuro2A, TA3 and CT26) were largely
unaffected upon Ifnγ treatment (Fig. 1A and B).
To unravel the possible mechanisms for Ifnγ insensitivity, we fo-
cused on differences in the downstream signal transduction pathways
in three tumor cell lines: H6, L929 (both sensitive to Ifnγ induced cell
death) and CT26 (resistant to Ifnγ induced cell death). To study the
Ifnγmediated signaling events, RT-PCR analysis of well known Ifnγ re-
sponsive genes was performed [4]. Transcripts for Irf1 and Lmp10 re-
vealed that these were induced by 6 h in H6 cells upon Ifnγ
treatment. However, the induction of the same transcripts was ob-
served by 12 h in L929 in response to Ifnγ. Interestingly, Ifnγ induced
expression of Irf1 and Lmp10 was detected by 6 h and increased maxi-
mally by 24 h in CT26 cells (Fig. 2A). Further, pStat1 amounts were in-
duced by 1 h in both H6 and L929; however pStat1 induction was
delayed in CT26 post Ifnγ treatment (Fig. 2B). Ifnγ induced MHC-I
amounts in H6, L929 and CT26 increased in a time-dependent manner;
however the extent of induction was reduced in CT26 (Fig. 2C and Sup-
plementary Fig. 2A). Thus, H6 and L929 were responsive to Ifnγ using
multiple criteria; however, CT26 was less responsive and demonstrated
delayed kinetics and did not undergo cell death.
3.2. Ifnγ induces cell death in NO and ROS producing tumor cell lines
As robust induction of NO and ROS was observed speciﬁcally in H6
and L929, i.e. in cell lines wherein Ifnγ induced cell death (Fig. 1 and
Supplementary Figs. 1B, C and 2B), further studies to address the regu-
lation of NO and ROS were designed. Ifnγ induced Nos2 in a timelar peroxynitrite in H6 and L929 cells treated with 25 and 50 U/ml of Ifnγ respectively for
respectively for 36 h and peroxynitrite was detected by confocalmicroscopy (B). H6 (left)
itor (LNMA and AG; 250 μMeach) and ROS inhibitor (PEG–CAT at 100 U/ml and PEG–SOD
and intracellular peroxynitritewasmeasured (C). H6 and L929 cellswere incubated either
γ respectively for 48 h and assayed for intracellular peroxynitrite, cell surface MHC-I (Kk)
eriments. The signiﬁcance is represented as * and #when individual conditionswere com-
Fig. 5. Induction of p47Phox andmitochondrial ROS is dependent on RNI and ROS in response to Ifnγ. H6 (left) and L929 (right) cellswere incubated either alone or pre-treated for 1 hwith
RNI inhibitors, i.e. LNMA (250 μM) and FeTPPS (50 μM), ROS inhibitor i.e. PEG–SOD (50 U/ml) and cultured in the presence or absence of 25 and 50 U/ml Ifnγ respectively for 24 h and
analysis of intracellular Nos2 (A), intracellular 3-nitrotyrosine (3-NT) (B), intracellular p47Phox (C) and mitochondrial ROS (D) amounts were performed. The data are represented as
mean ± SE from two independent experiments. The signiﬁcance is represented as * and # when individual conditions were compared to cells alone and Ifnγ alone controls respectively.
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not in CT26 (Fig. 2A andD). Also, Ifnγ treatment led to increase in nitrite
amounts as a function of time in the supernatants of H6 and L929 butnot CT26 (Fig. 2E). ROS was induced in a time dependent manner in
H6 and L929; interestingly, L929 exhibited enhanced induction of NO
and ROS amounts compared to H6 although it required higher dose of
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sulted in low amounts of ROS induction in CT26 (Fig. 2F and Supple-
mentary Fig. 1C). Confocal imaging analysis further conﬁrmed the
intracellular production of both NO and ROS in the Ifnγ treated H6
and L929 (Supplementary Fig. 3).
3.3. NO acts upstream of ROS to induce cell death in response to Ifnγ
To understand the contributions and interplay of NO and ROS during
Ifnγ induced cell death, inhibitors of nitric oxide synthase, i.e. LNMA and
aminoguanidine (AG), and cell-permeable mimetics of catalase and su-
peroxide dismutase, i.e. polyethylene-glycol-catalase (PEG–CAT) and
PEG–superoxide dismutase (PEG–SOD), that preferentially scavenge in-
tracellular H2O2 and superoxide were used. Consistent with a previous
study [15], Ifnγ stimulated cell surface expression of MHC-I remained
unaltered in the presence of NO or ROS inhibitors in both H6 and L929
(Fig. 3A). PEG–CAT and PEG–SOD quenched Ifnγ induced ROS, but not
nitrite amounts in H6 and L929. Importantly, LNMA and AG not only ef-
fectively inhibited Ifnγ induced nitrite amounts but also considerably
abrogated induced ROS in both the cell lines (Fig. 3B and C and Supple-
mentary Fig. 4B). Furthermore, LNMA and AG almost completely
inhibited Ifnγ induced cell death. However, the ability of ROS quenchers
PEG–CAT and PEG–SOD in inhibiting Ifnγ-induced cell death was com-
paratively less even at higher doses (Fig. 3D and Supplementary
Fig. 4A). Taken together, these results established that Ifnγ-induced
NO acted upstream of ROS production, which leads to cell death in H6
and L929.
3.4. Peroxynitrite, downstream to NO and ROS, mediates Ifnγ-induced
cell death
Peroxynitrite, an unstable but potent oxidant, is formed upon
superoxidation of NO [19]. As both NO and ROS were induced in re-
sponse to Ifnγ in H6 and L929 cells (Figs. 2 and 3), the formation and po-
tential roles of peroxynitrite, if any, were monitored. Both H6 and L929
exhibited a time-dependent increase in intracellular amounts of
peroxynitrite (Fig. 4A and Supplementary Fig. 2C). Although, L929 pro-
duced greater NO and ROS amounts in comparison to H6 cells, the
amount of peroxynitrite induced was almost half of that observed in
H6 cells in response to Ifnγ (Fig. 4A). This observation was further
strengthened using confocal microscopy to study peroxynitrite
amounts in Ifnγ treated H6 and L929 cells (Fig. 4B). Experiments with
CT26 cells revealed that treatment with Ifnγ did not induce any signiﬁ-
cant increase in peroxynitrite amounts in the same (Supplementary Fig.
5A and B). Also, unlike TG-PECs, which responded to LPS treatment by
producing nitrite in a dose dependent manner, CT26 cells failed to pro-
duce any detectable nitrite even upon LPS stimulation (Supplementary
Fig. 5C and D). Therefore, NO production in CT26 cells remains dormant
irrespective of the inﬂammatory stimuli used, e.g. Ifnγ or LPS.
To understand the respective contributions of NO and ROS to the
formation of peroxynitrite, experiments were performed with inhib-
itors to respective radicals. LNMA and AG treatment signiﬁcantly
reduced Ifnγ-induced peroxynitrite amounts. On the other hand,
PEG–CAT treatment had little effect and PEG–SOD treatment mod-
estly reduced peroxynitrite amounts in both the cell lines (Fig. 4C).
To address the functional contributions of increased peroxynitrite
amounts during Ifnγ mediated cell death, a speciﬁc peroxynitrite
scavenger and decomposition catalyst FeTPPS was used. As expected,
FeTPPS signiﬁcantly inhibited peroxynitrite generation in response
to Ifnγ without affecting the cell surface expression of induced
MHC-I. Also, inhibition of peroxynitrite did not affect induced NO
amounts, however ROS amounts were considerably reduced upon
FeTPPS treatment in Ifnγ treated H6 and L929. Most importantly, re-
duction in cell viability was markedly rescued by FeTPPS treatment
in Ifnγ treated H6 and L929 (Fig. 4D). Together, these results demon-
strate that peroxynitrite was induced in a NO and superoxidedependent manner in H6 and L929 that contributed to further ROS
production leading to cell death in response to Ifnγ.
3.5. Ifnγ induces p47Phox and mitochondrial ROS amounts in a RNI and
ROS dependent manner
What are the sources of ROS in response to Ifnγ? This aspect was ad-
dressed by studying the regulation and contributions of NADPHoxidase,
which is known to be induced with Ifnγ [1,4] and mitochondrial ROS.
H6 and L929 cells were treated with Ifnγ in the presence or absence of
inhibitor of Nos (LNMA), SOD mimic (PEG–SOD) and peroxynitrite
scavenger (FeTPPS). The induction of Nos2 amounts upon Ifnγ treat-
ment remained unaffected irrespective of the abovementioned com-
pounds used (Fig. 5A). However, the induction in nitrosylation of
tyrosine in cellular proteins, as detected using 3-NT staining, was
inhibited partially by PEG–SOD, while LNMA and FeTPPS treatment al-
most completely abrogated the induction in 3-NT amounts in response
to Ifnγ (Fig. 5B). Analysis of p47Phox amounts, a component of the
NADPH oxidase complex, revealed that it is induced in response to
Ifnγ. Treatment with PEG–SOD and FeTPPS marginally reduced the in-
duction in p47Phox amounts; however, LNMA treatment completely
inhibited induction in p47Phox in response to Ifnγ (Fig. 5C). Thus, in-
duction of 3-NT amounts and p47Phox amounts was dependent on
RNI and ROS generated in response to Ifnγ.
Next, to evaluate the regulation and contribution of mitochondrial
ROS in response to Ifnγ, analysis with a mitochondrial superoxide de-
tecting dye, MitoSox red was performed. First, mitochondrial ROS was
induced in both H6 as well as L929 cells upon Ifnγ treatment. Impor-
tantly, this induction in mitochondrial ROS was inhibited efﬁciently
upon treatment of cells with LNMA or PEG–SOD or FeTPPS (Fig. 5D).
Therefore, mitochondrial ROS is induced downstream to RNI and con-
tributes to the overall ROS produced in response to Ifnγ.
3.6. Inhibitors to RNI and ROS reduce Ifnγ induced apoptosis related events
in H6 and L929
Free radicals can induce apoptotic cell death in a context-dependent
manner [27]. Hence, the effects of Ifnγ on cell proliferation and apopto-
siswere investigatedusing the BrdU incorporation andAnnexin-V bind-
ing assays, respectively. Ifnγ treatment signiﬁcantly inhibited the
growth of cells as early as 12 h and 24 h in the case of H6 and L929 re-
spectively. However, Ifnγ treatment induced signiﬁcant apoptosis of
both the cell lines at a much later time point in comparison to growth
suppression (Supplementary Fig. 6A and B). In both cell lines, the extent
of apoptosis coincided with the induction of active Caspase 3 and Cas-
pase 9, aswell as increase in the loss ofmitochondrialmembrane poten-
tial, ΔΨm (Supplementary Fig. 6C, D and E). Also, no induction of active
Caspase 8, associated with extrinsic apoptotic pathway, was observed
upon Ifnγ treatment in both the cell lines (data not shown). Therefore,
Ifnγ initially induced growth suppression, which was followed by
events associated with intrinsic apoptotic pathway in H6 and L929.
To understand the contributions of RNI and ROS to Ifnγ-induced ap-
optosis, studies with speciﬁc inhibitors were performed. The inhibitors
of RNI, i.e. LNMA, AG and FeTPPS reduced the ΔΨm loss and induction
of active Caspase 3 and Caspase 9 much better in response to Ifnγ in
comparison to the ROS inhibitors, i.e. PEG–CAT and PEG–SOD, in both
H6 and L929 (Fig. 6A, B and C). Consequently, LNMA, AG and FeTPPS ab-
rogated apoptosis in response to Ifnγ more effectively than PEG–CAT
and PEG–SOD in H6 and L929 (Fig. 6D). Hence, RNI and ROS contributed
to the intrinsic pathway of apoptosis induced as a result of Ifnγ treat-
ment in H6 and L929.
3.7. SNAP and t-BHP induced cell death is peroxynitrite-dependent
To understand the direct and individual roles of free radicals, SNAP
(a potent NO donor) and t-BHP (a potent ROS inducer) were employed.
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dependentmanner in bothH6 and L929 (Supplementary Fig. 7A). How-
ever, only SNAP, but not t-BHP, treatment led to nitrite production (Sup-
plementary Fig. 7B). Importantly, treatment with either SNAP or t-BHP
induced ROS and peroxynitrite (Supplementary Fig. 7C and D). Hence,
cell death induced by SNAP and t-BHP is accompanied by induction in
ROS and peroxynitrite amounts in both the cell lines.
To evaluate the individual contributions of RNI and ROS during SNAP
or t-BHP induced cell death, several inhibitors were used. The amounts
of SNAP or t-BHP used were similar to the loss in cell viability observed
in cells treated with Ifnγ. Treatment with inhibitors, i.e. LNMA, PEG–
CAT, PEG–SOD and FeTPPS, did not affect SNAP induced nitrite amounts
(Fig. 7A). However, PEG–CAT, PEG–SOD and FeTPPS, but not LNMA,
were efﬁcient in reducing SNAP and t-BHP induced ROS and
peroxynitrite in both H6 and L929 (Fig. 7B and C). As expected, LNMA
treatment had no effect on SNAP and t-BHP induced reduction in cell vi-
ability. However, PEG–CAT and PEG–SOD led to a moderate yet signiﬁ-
cant increase in viability of cells in response to SNAP or t-BHP. Most
importantly, FeTPPS treatment signiﬁcantly enhanced cell viability in
response to SNAP or t-BHP (Fig. 7D). Therefore, peroxynitrite plays a
major role in mediating cell death induced by SNAP or t-BHP treatment
in H6 and L929.
3.8. Jnk activation regulates the extent of sensitivity to Ifnγ induced cell death
Mitogen activated protein kinases mediate expression of Ifnγ regu-
lated genes in macrophages [28]. In fact, Jnk mediates RAW cell death
in response to the combined action of LPS and Ifnγ [29]. To assess the
roles of mitogen activated protein kinase signaling pathways in regula-
tion of Ifnγ-induced free radicals, the expression and function of Jnkwas
ﬁrst evaluated. Ifnγ treatment led to phosphorylation of Jnk (pJnk) in a
time dependent manner in H6 and L929, but not in CT26 (Fig. 8A). A
strong correlation was observed between Ifnγ-induced Jnk and cells
that were sensitive to Ifnγ-mediated cell death, i.e. H6 and L929
(Fig. 8A and Figs. 2 and 3). To understand the functional role of Jnk acti-
vation in response to Ifnγ, a speciﬁc inhibitor, i.e. SP600125 (Jnki) was
used. Treatment with Jnki did not reduce Ifnγ induced NO in both H6
and L929 (Fig. 8B). However, Jnk inhibition reduced both ROS and
peroxynitrite amounts in response to Ifnγ in H6 and L929 (Fig. 8C and
D). Importantly, inhibition of NO as well as peroxynitrite reduced Ifnγ
induced activation of Jnk in these cells (Fig. 8E). Indeed, inhibition of
Jnk activation rescued Ifnγ mediated cell death in both cell lines
(Fig. 8F). It is important to point out that pJnk was induced maximally
and sustained for a longer time in H6 compared to L929. Also, the rescue
in cell death upon inhibition of Jnk in H6 was higher/greater than that
observed in L929 cells (Fig. 8F). These studies clearly demonstrated
that the induction of Jnk modulated the amounts of ROS and
peroxynitrite and was functionally important during Ifnγ-induced cell
death.
3.9. Ifnγ induces death of CT26, EL4 and Neuro2A cells in combination with
SNAP or t-BHP
As Ifnγ induced RNI and ROS were found to mediate cell death in H6
and L929, the direct effects of the combination of SNAP and t-BHP were
tested on H6, L929 and CT26. Dose titration experiments exhibited re-
duced viability of H6, L929 and CT26 cells to the combination of SNAP
and t-BHP at concentrations that individually either SNAP or t-BHP
was less effective in inducing cell death (Supplementary Fig. 8). Hence,Fig. 6. Inhibitors toNO andROS abrogate Ifnγ induced loss inmitochondrial potential, caspase act
or pre-treated for 1 h with RNI inhibitors, i.e. LNMA and AG (250 μM each), ROS inhibitors, i.e.
50 μM, and cultured in the presence or absence of 25 and 50 U/ml Ifnγ respectively for 48 h. Post
loss (A), intracellular cleaved Caspase 9 positive cells (B), intracellular cleaved Caspase 3 positiv
from three independent experiments. The signiﬁcance is represented as * and # when individuIfnγ induced cell death can be mimicked by directly supplementing
cells with the combination of RNI and ROS donors.
As CT26 did not produce high amounts of NO or ROS and resisted cell
death in response to Ifnγ, the effects of SNAP or t-BHP in combination
with Ifnγ were studied. The addition of Ifnγ to SNAP or t-BHP treated
cells did not modulate nitrite amounts (Fig. 9A and C). Treatment with
Ifnγ (100 U/ml) along with 25–100 μM SNAP led to signiﬁcant cell
death, that was not observed at same concentrations of Ifnγ or SNAP
alone (Fig. 9B). Similarly, 50 μM t-BHP reduced viability by ~50% and
synergistic effect was more pronounced at low doses of t-BHP together
with 100 U/ml Ifnγ (Fig. 9D). Importantly, Ifnγ in combination with
SNAP or t-BHP led to enhanced peroxynitrite formation which was ef-
fectively scavenged by FeTPPS (Fig. 9E and F). Accordingly, treatment
with FeTPPS signiﬁcantly abrogated the synergistic effect on cell viabil-
ity observed in the presence of Ifnγ and SNAP or t-BHP (Fig. 9G and H).
To further extend the generality of our observations, studies on the
effects of Ifnγ along with NO and ROS donors were performed on two
other cell lines that are resistant to death by Ifnγ alone, EL4 and
Neuro2A. The addition of Ifnγ or SNAP or t-BHP alone did not induce
any signiﬁcant difference in the number of viable EL4 and Neuro2A
cells. However, the combination of Ifnγ with 100 μM of SNAP or 50
μM of t-BHP leads to signiﬁcant decrease in the number of viable cells.
Importantly, this decrease in the number of viable cells was rescued
upon treatment with FeTPPS in both the cell types (Fig. 10). Therefore,
the combination of Ifnγ and a NO donor or ROS inducer leads to cell
death in otherwise resistant three distinct cell types, CT26, EL4 and
Neuro2A.
4. Discussion
Despite being a potent immunotherapeutic cytokine, administration
of Ifnγ in humanpatients to treat tumors has shown little promise [6,30,
31]. There are multiple reasons for this phenomenon, for e.g. an incom-
plete understanding of the complex interactions between Ifnγ and the
in vivo tumor microenvironment. Also, the mechanisms by which tu-
mors evade cell mediated immunosurveillance leading to Ifnγ resis-
tance are poorly understood [32,33]. In this study, the “direct” effect of
Ifnγ on several tumor cell lines was studied. Ifnγ mediated MHC-I in-
ductionwas observed in all cell lines, albeit to different extents (Supple-
mentary Fig. 1A). However, out of the seven cell lines tested, only H6
and L929 displayed susceptibility to Ifnγ induced cell death as depicted
by the reduced cell proliferation and cell viability (Fig. 1). All cell types
are not known to be sensitive to the cytotoxic or cytostatic effects of
Ifnγ [12–14] and the proximal signaling events and gene expression in
response to Ifnγ were investigated. The induction of Irf1 and Lmp10
was observed in H6, L929 and CT26 with differences in the kinetics.
The activation of Stat1 was rapid in case of H6 and L929 but delayed
in CT26 cells. Also, the extent of MHC-I induction was less in CT26 in
comparison to H6 and L929 (Fig. 2). Overall, CT26 was responsive to
Ifnγ although the fold induction and kinetics were delayed in compari-
son to H6 and L929.
There are numerous studies on the mechanistic insights regarding
the growth suppressive actions of Ifnγ; however, the speciﬁc interac-
tions and contributions of oxidative and nitrosative stress have not
been well elucidated. A previous study demonstrated the involvement
of RNI and ROS during Ifnγ-mediated growth suppression of H6 cells, al-
though the individual roles of these radicals were not delineated [15].
Interestingly, NOS2 expression in human hepatoma cell lines renders
them resistant to Ifnγ mediated cell death due to the anti-apoptotic
role of NO [14]. On the other hand, our study revealed that all theivation and apoptotic cell death.H6 (left) and L929 (right) cellswere incubated either alone
PEG–CAT at 100 U/ml and PEG–SOD at 50 U/ml, and a peroxynitrite scavenger, FeTPPS at
treatment, the analysis of percentage of cells exhibitingmitochondrial membrane potential
e cells (C) and apoptotic cells (D) were performed. The data are represented as mean± SE
al conditions were compared to cells alone and Ifnγ alone controls respectively.
Fig. 7. SNAP and t-BHP induced cell death ismediated by peroxynitrite. H6 (left) and L929 (right) cells were incubated either alone or pre-treated for 1 hwith RNI inhibitors, i.e. LNMAand
AG (250 μM each), ROS inhibitors, i.e. PEG–CAT at 100 U/ml and PEG–SOD at 50 U/ml, and peroxynitrite scavenger, FeTPPS at 50 μM, and cultured in the presence or absence of 250 μM
SNAP or 50 μM t-BHP for 48 h and analyzed for nitrite (A), intracellular ROS (B), peroxynitrite (C) and cell viability (D). The data are represented as mean ± SE from three independent
experiments. The signiﬁcance is represented as * and # when individual conditions were compared to cells alone and SNAP or t-BHP alone controls respectively.
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to Ifnγ (Supplementary Fig. 1B). We also demonstrated that Nos2 in-
duction in response to Ifnγ caused a robust and sustained accumulation
of nitrite in both H6 and L929. However, there was no expression and
induction of Nos2 in CT26, whichwas consistent with the failure to pro-
duce nitrite upon stimulation with Ifnγ or with LPS (Fig. 2 and Supple-
mentary Fig. 5C). Also, the induction of ROS was higher in H6 and
L929 in comparison to CT26 in response to Ifnγ (Fig. 2). Therefore, a
strong correlation was observed for cells that produced high amounts
of NO and ROS and sensitivity to Ifnγ induced cell death.
There are several studies that demonstrate the interrelationship be-
tween ROS and RNI in the regulation of cell growth. Catalase reduces the
activity of NOS and formation of peroxynitrite revealing a cross talkbetween the RNI and ROS systems [34]. Interestingly, NO increases the
amounts of H2O2 in endothelial cells by inhibiting the enzymes involved
in degradation, e.g. catalase and glutathione peroxidase [35]. Depending
on the cellular amounts of NO, it can act as both pro- as well as anti-
apoptotic molecule during cancer progression [17,36]. NO in the ab-
sence of an oxidizing environment nitrosylates caspases and stimulates
the production of cGMP leading to the inhibition of apoptosis. On the
other hand, NO in the presence of an oxidizing environment leads to in-
crease in the amounts of peroxynitrite leading to cell death [37]. In fact,
non-transformed ﬁbroblasts produce less ROS and are unaffected by
NOS donor. However, transformed ﬁbroblasts produce high amounts
of ROS and undergo death due to the generation of peroxynitrite, in
the presence of a NO donor [38]. The apoptosis resulting from the
Fig. 8. Ifnγ induced Jnk activation regulates ROS and peroxynitrite amounts to mediate cell death. Kinetic analysis of the intracellular levels of p-Jnk in Ifnγ treated H6 (25 U/ml), L929
(50 U/ml) and CT26 (50 U/ml) cells (A). Analysis of nitrite amounts (B) and cell viability (F) of H6 (left) and L929 (right) cells treated in the absence or presence of indicated amounts
of Jnk inhibitor SP600125 (Jnki) and cultured alone or with 25 U/ml and 50 U/ml of Ifnγ for 36 h and 48 h respectively. The amount of intracellular ROS (C) and peroxynitrite (D) in
H6 (left) and L929 (right) cells treated in the absence or presence of Jnki (10 μM) and cultured alone or with 25 U/ml and 50 U/ml of Ifnγ for 36 h and 48 h respectively. The intracellular
levels of p-Jnk in H6 (left) and L929 (right) cells treated in the absence or presence of LNMA (250 μM) as well as FeTPPS (50 μM) and cultured alone or with 25 U/ml and 50 U/ml of Ifnγ
respectively for 12 h (E). The data are represented asmean±SE from two independent experiments. The signiﬁcance is represented as * and#when individual conditionswere compared
to cells alone and Ifnγ alone controls respectively.
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Fig. 10. EL4 andNeuro2A cells undergo cell deathwhen treatedwith a combination of Ifnγ
and SNAP or t-BHP, in a peroxynitrite-dependent manner. EL4 (A) and Neuro2A (B) cells
were treatedwith indicated concentrations of SNAP (μM) or t-BHP (μM) either alone or in
combination with 100 U/ml of Ifnγ for 48 h and in the presence or absence of 50 μM
FeTPPS before analysis of the percentage of viable cells was performed. The data are rep-
resented as mean ± SE from two independent experiments.
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oxidation, activate the mitochondrial permeability transition pore etc.
[39]. In HepG2 cells, there is a bimodal effect of a NO donor on ROS
amounts: in the initial 4 h, there is lowering of ROS whereas at later
time points ROS amounts increase [40]. The inhibition of NADPH oxi-
dase, but not mitochondrial respiration or xanthine oxidase, in micro-
vascular endothelial cells led to decrease in Nos2 expression [41]. In
PC12 cells, t-BHP generated superoxide together with endogenous NO
generates peroxynitrite which increases DNA damage [42,43]. To ascer-
tain the relationship between NO and ROS, we employed different NOSFig. 9. Ifnγ in combinationwith SNAPor t-BHP leads to CT26 cell death in a peroxynitrite-depend
(C–D) either alone or in combination with 100 U/ml of Ifnγ for 48 h and analysis of nitrite in t
treated with 50 μM FeTPPS for 1 h and then treated with 100 μM SNAP or 50 μM t-BHP or a co
for 48 h and analysis of peroxynitrite (E–F) and cell viability (G–H) respectively were assayed.
icance is represented as *, # andΔwhen individual conditionswere compared to cells alone con
The signiﬁcance is represented as *, ^, # and Δwhen individual conditions were compared to
respectively in panels E and G. The signiﬁcance is represented as *, # and Δ when individual c
controls respectively in panels F and H.inhibitors andROS scavengers to study their effects on Ifnγmediated re-
sponses. Consistent with our previous report [15], MHC-I expression
was independent of induced nitrosative and oxidative stress in response
to Ifnγ. Nos2 is known to be induced by Ifnγ [19] and this enhancement
was not inhibited with LNMA, PEG–SOD and FeTPPS (Fig. 5). Also, three
distinct ROS inhibitors, i.e. apocynin, PEG–CAT and PEG–SOD, did not af-
fect Ifnγ induced nitrite but partially rescued the viability of H6 and
L929 (Supplementary Fig. 4). On the other hand, two NOS inhibitors,
i.e. LNMA and aminoguanidine, lowered induced nitrite as well as ROS
amounts and greatly enhanced the viability of H6 and L929 cells in re-
sponse to Ifnγ (Fig. 3). Studies were performed to better understand
the source of Ifnγ-induced ROS in H6 and L929. As shown in Fig. 5,
both NADPH oxidase and mitochondrial ROS contribute to the major
amounts of Ifnγ-induced ROS. Also, treatment with LNMA reduced the
amounts of Ifnγ-induced NADPH oxidase and mitochondrial ROS and,
consequently, total cellular amounts of ROS. Together, the data estab-
lishes that Ifnγ induced NO is upstream to ROS induction and is crucial
for the induction of apoptosis.
Peroxynitrite has been previously implicated as the molecule re-
sponsible for cytotoxicity during NO mediated cell death [37–39,44,
45]. Surprisingly, the role of peroxynitrite during Ifnγ induced cell
death is poorly investigated. Ifnγ treatment resulted in time dependent
increase in peroxynitrite amounts in both H6 and L929, but not CT26
cells (Fig. 4 and Supplementary Fig. 5). Notably, the higher induction
of peroxynitrite in H6 in response to Ifnγ correlated with greater sensi-
tivity in comparison to L929 (Fig. 4). It is unclear as to why the high
amounts of NO and ROS in L929 cells failed to be converted into
peroxynitrite (Fig. 2). One possibility is that there are differences in lo-
cation of superoxide radicals and NO, keeping in mind that the former
are less able to diffuse across biological membranes. Another possibility
is that L929 may contain high amounts of intracellular quenchers of
peroxynitrite, e.g. metalloporphyrins, peroxiredoxins etc [44]. Further-
more, peroxynitrite generation occurs only when equal concentrations
of NO and superoxide exist and is notmerely proportional to the net ex-
cess amounts of these two precursor free radicals [46]. Also, Ifnγ in-
duced 3-NT, which is a marker for the presence of active peroxynitrite
(Fig. 5). In addition, quantifying 3-NT mounts and demonstrating its
modulation with RNI and ROS quenchers was a key end point biochem-
ical assay that was distinct from the use of ﬂuorogenic probes used to
measure ROS and peroxynitrite. Importantly, enhanced generation of
peroxynitrite and 3-NT amounts correlated with sensitization to Ifnγ,
which was abrogated by FeTPPS (Figs. 4 and 5). Both NO and ROS play
crucial roles and peroxynitrite acts as a major downstream effector in
the activation of mitochondrial death pathway by Ifnγ (Fig. 6).
Treatment with t-BHP induced ROS but not nitrite; on the other
hand, treatmentwith SNAP induced both nitrite aswell as ROS amounts
(Fig. 7, Fig. 9 and Supplementary Fig. 7). What is the source of NO and
ROS in cells treated with either SNAP or t-BHP in the absence of Ifnγ?
It is likely that endogenous amounts of NO and ROS are present which
combine alongwith a ROS inducer orNOdonor or to increase the forma-
tion of peroxynitrite. In fact, endogenousNOhas been shown to contrib-
ute to peroxynitrite formation upon t-BHP treatment [38,42,43]. These
observations are consistent with previous studies that show that
peroxynitrite induces various positive-feedback cycles [47] leading to
the generation of NO and ROS, culminating in cell death. CT26 cells
were unresponsive to Ifnγ even at very high concentrations due toentmanner. CT26 cellswere treatedwith indicated concentrations of SNAP (A–B)or t-BHP
he supernatant and cell viability was performed. CT26 cells were either untreated or pre-
mbination of both and 100 μM SNAP or 50 μM t-BHP in combination with 100 U/ml Ifnγ
The data are represented as mean ± SE from three independent experiments. The signif-
trols, t-BHP alone or SNAP alone control and Ifnγ alone control respectively in panels A–D.
cells alone, t-BHP alone, SNAP alone and a combination of t-BHP and SNAP alone controls
onditions were compared to Ifnγ alone, Ifnγ with t-BHP alone and Ifnγ with SNAP alone
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However, CT26, Neuro2a and EL4 cells were susceptible to Ifnγmediat-
ed cell death in the presence of SNAP or t-BHP in a peroxynitrite depen-
dent manner (Figs. 9 and 10). Notably, FeTPPS greatly diminished ROS
as well as peroxynitrite amounts induced by SNAP or t-BHP in H6 and
L929 (Fig. 7). Overall, our results overwhelmingly show that Ifnγ in-
duced peroxynitrite plays a critical role during cell death.
To better understand the roles of signalingmolecules involved in the
regulation of free radicals, the role of Jnk was investigated. During Ifnγ
signaling in bone marrow derived macrophages, Jnk1 has been shown
to modulate the expression of genes involved in antigen processing
and presentation [28]. The combination of Ifnγ and Tnfα, but not the cy-
tokines alone, led to increased activation of Jnk, production of ROS and
death of pancreatic beta cells [48]. Also, the combination of LPS and
Ifnγ induces NO which activates Jnk causing death of the RAWmacro-
phage cell line. Here, the dephosphorylation of Bax is NO-independent
whereas the phosphorylation of Bim is NO-dependent [29]. The high
amounts of Ifnγ produced upon in vivo infection with S. Typhimurium
led to the activation of Jnk, which contributed to death of thymocytes
[49]. Interestingly, Jnk phosphorylation was observed in H6 and L929,
but not CT26 cells, upon treatment with Ifnγ. The greater fold induction
of Jnk phosphorylation in H6 correlatedwell with its enhanced sensitiv-
ity to Ifnγ-induced cell death. In addition, dose studies with SP600125
demonstrated that Jnk activation was responsible to a great extent for
the Ifnγ mediated death of H6 and to a partial extent in L929 cells
(Fig. 8). Notably, inhibitors to Erk and p38 Mapk did not increase the
survival of H6 and L929 cells in response to Ifnγ (data not shown). Fur-
ther studies demonstrated that NOwas upstream to Jnk activation as in-
hibition of NO reduced Ifnγ induced Jnk activation. Also, nitrite amounts
were similar upon Ifnγ treatment in the presence or absence of the Jnk
inhibitor. However, it appears that Jnk activation and peroxynitrite gen-
eration co-regulate each other as inhibitionwith FeTPPS lowered Jnk ac-
tivation as well as ROS. Also, peroxynitrite amounts were reduced upon
Jnk inhibition (Fig. 8). These studies clearly document the distinct roles
of Jnk in regulation of NO, ROS and peroxynitrite. Overall, the data dem-
onstrates Ifnγ-induced NO to be the key initiator and the subsequent
generation of effectors, e.g. Jnk, ROS and peroxynitrite, contribute to
Ifnγ induced cell death (Fig. 11).Fig. 11. A schematic model depicting the contributions of NO, pJnk, ROS and peroxynitrite
during Ifnγmediated cell death. Ifnγ-induced NO is the key initiator which activates mul-
tiple pathways leading to increased amounts of ROS, peroxynitrite and activation of Jnk.
These three effectors also regulate each other and lead to cell death.Thus far, studies have demonstrated the roles of proximalmolecules
in the Ifnγ signal transduction pathway which play important roles in
determining sensitivity or resistance to this cytokine [12–14]. This
study clearly demonstrates the important role of high amounts of RNI
and ROS which act as a hallmark in cells that are sensitive to Ifnγ. The
maximal reduction in the number of Ifnγ induced apoptotic cells was
observed upon treatment with LNMA, AG or FeTPPS compared to
PEG–CAT or PEG–SOD (Fig. 6). Importantly, CT26, EL4 and Neuro2A
cells which were resistant to Ifnγ mediated cell death demonstrated
sensitivity when Ifnγ is added in combination of low concentrations of
NO donor or ROS inducer (Figs. 9 and 10). It is important to understand
that differential effects of NO have been reported with respect to tumor
progression. In some cases, NO enhances, whereas in other studies it re-
presses, tumor growth. These differential effects of NO are dependent
on the types of cells generating NO, the amounts produced and the abil-
ity of NO to affect various cellular activities, e.g. DNA damage,migration,
invasion, survival, angiogenesis etc. Consequently, several studies have
reported the tumor suppressing effects of donors of NO or inhibitors
of NOS/NO scavengers in various models [17,36]. Indeed, some NO do-
nors are effective in reducing tumor growth [50]. This study is, most
likely, relevant for tumors that are sensitive to NO. Consequently,
using the combination of Ifnγ treatment and NO donorsmay be a useful
strategy to reduce tumor progression. Theseﬁndings are signiﬁcant as it
opens up the possibility of a wider number of tumors to be made sensi-
tive to the combined action of Ifnγ and a NO donor. Although further
studies and clinical evaluations are required, this study places a “proof
of concept” to test the efﬁcacy of the combination of Ifnγ andNO donors
in reducingmalignancies that are classically resistant to the action of ei-
ther Ifnγ or NO donors alone.
Acknowledgements
Wewould like to thankDr. Omana Joy and othermembers, Division-
al FACS facility, and Meenakshi Sen, Divisional Confocal facility, IISc for
extending their help in acquiring samples. The suggestions and support
given by all members, especially Rajkumar Dhanaraju, of the DpN lab
deserve a special mention. SR and BSC were supported by fellowships,
DBT-RA and DBT-JRF, respectively. This study was funded by a grant
from CSIR (37(1418)/10/EMR-II), Government of India.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.06.014.
References
[1] U. Boehm, T. Klamp, M. Groot, J.C. Howard, Cellular responses to interferon-γ, Annu.
Rev. Immunol. 15 (1997) 749–795.
[2] K. Schroder, P.J. Hertzog, T. Ravasi, D.A. Hume, Interferon-gamma: an overview of
signals, mechanisms and functions, J. Leukoc. Biol. 75 (2004) 163–189.
[3] C.H. Miller, S.G. Maher, H.A. Young, Clinical use of interferon-gamma, Ann. N. Y.
Acad. Sci. 1182 (2009) 69–79.
[4] B. Saha, S.J. Prasanna, B. Chandrasekar, D. Nandi, Gene modulation and immunoreg-
ulatory roles of interferon gamma, Cytokine 50 (2010) 1–14.
[5] K. Taniguchi, M. Petersson, P. Höglund, R. Kiessling, G. Klein, K. Kärre, Interferon
gamma induces lung colonization by intravenously inoculated B16 melanoma
cells in parallel with enhanced expression of class I major histocompatibility com-
plex antigens, Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 3405–3409.
[6] M.R. Zaidi, G. Merlino, The two faces of interferon-γ in cancer, Clin. Cancer Res. 17
(2011) 6118–6124.
[7] C.-Q. Chu, S. Wittmer, D.K. Dalton, Failure to suppress the expansion of the activated
CD4+ T cell population in Interferon γ-deﬁcient mice leads to exacerbation of ex-
perimental autoimmune encephalomyelitis, J. Exp. Med. 192 (2000) 123–128.
[8] R. Sun, B. Gao, Negative regulation of liver regeneration by innate immunity (natural
killer cells/interferon-gamma), Gastroenterology 127 (2004) 1525–1539.
[9] D.H. Kaplan, V. Shankaran, A.S. Dighe, E. Stockert, M. Aguet, L.J. Old, R.D. Schreiber,
Demonstration of an interferon γ-dependent tumor surveillance system in immu-
nocompetent mice, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 7556–7561.
[10] M. Chawla-Sarkar, D.J. Lindner, Y.F. Liu, B.R. Williams, G.C. Sen, R.H. Silverman, E.C.
Borden, Apoptosis and interferons: role of interferon-stimulated genes as mediators
of apoptosis, Apoptosis 8 (2003) 237–249.
2661S. Rakshit et al. / Biochimica et Biophysica Acta 1843 (2014) 2645–2661[11] Y. Zhou, C.M.Weyman, H. Liu, A. Almasan, A. Zhou, IFN-gamma induces apoptosis in
HL-60 cells through decreased Bcl-2 and increased Bak expression, J. Interferon Cy-
tokine Res. 28 (2008) 65–72.
[12] P. Bernabei, E.M. Coccia, L. Rigamonti, M. Bosticardo, G. Forni, S. Pestka, C.D. Krause,
A. Battistini, F. Novelli, Interferon-gamma receptor 2 expression as the deciding fac-
tor in human T, B, and myeloid cell proliferation or death, J. Leukoc. Biol. 70 (2001)
950–960.
[13] A.S. Dighe, E. Richards, L.J. Old, R.D. Schreiber, Enhanced in vivo growth and resis-
tance to rejection of tumor cells expressing dominant negative IFN gamma recep-
tors, Immunity 1 (1994) 447–456.
[14] N. Vadrot, A. Legrand, E. Nello, A.F. Bringuier, R. Guillot, G. Feldmann, Inducible nitric
oxide synthase (iNOS) activity could be responsible for resistance or sensitivity to
IFN-gamma-induced apoptosis in several human hepatoma cell lines, J. Interferon
Cytokine Res. 26 (2006) 901–913.
[15] S.J. Prasanna, B. Saha, D. Nandi, Involvement of oxidative and nitrosative stress in
modulation of gene expression and functional responses by IFNgamma, Int.
Immunol. 19 (2007) 867–879.
[16] M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M.Mazur, J. Telser, Free radicals and an-
tioxidants in normal physiological functions and human disease, Int. J. Biochem. Cell
Biol. 39 (2007) 44–84.
[17] G.A. Blaise, D. Gauvin, M. Gangal, S. Authier, Nitric oxide, cell signaling and cell
death, Toxicology 208 (2005) 177–192.
[18] M.L. Circu, T.Y. Aw, Reactive oxygen species, cellular redox systems, and apoptosis,
Free Radic. Biol. Med. 48 (2010) 749–762.
[19] J. MacMicking, Q.W. Xie, C. Nathan, Nitric oxide and macrophage function, Annu.
Rev. Immunol. 15 (1997) 323–350.
[20] T.J. Gross, K. Kremens, L.S. Powers, B. Brink, T. Knutson, F.E. Domann, R.A. Philibert,
M.M. Milhem, M.M. Monick, Epigenetic silencing of the human NOS2 gene:
rethinking the role of nitric oxide in human macrophage inﬂammatory responses,
J. Immunol. 192 (2014) 2326–2338.
[21] Y. Watanabe, O. Suzuki, T. Haruyama, T. Akaike, Interferon-gamma induces reactive
oxygen species and endoplasmic reticulum stress at the hepatic apoptosis, J. Cell.
Biochem. 89 (2003) 244–253.
[22] K. Kanki, T. Kawamura, Y. Watanabe, Control of ER stress by a chemical chaperone
counteracts apoptotic signals in IFN-gamma-treated murine hepatocytes, Apoptosis
14 (2009) 309–319.
[23] S.J. Prasanna, D. Nandi, The MHC-encoded class I molecule, H-2Kk, demonstrates
distinct requirements of assembly factors for cell surface expression: roles of TAP,
Tapasin and beta2-microglobulin, Mol. Immunol. 41 (2004) 1029–1045.
[24] S. Malu, S. Srinivasan, P. Kumar Maiti, D. Rajagopal, B. John, D. Nandi, IFN-gamma
bioassay: development of a sensitive method by measuring nitric oxide production
by peritoneal exudate cells from C57BL/6 mice, J. Immunol. Methods 272 (2003)
55–65.
[25] B. Chandrasekar, M. Deobagkar-Lele, E.S. Victor, D. Nandi, Regulation of chemokines,
CCL3 and CCL4, by interferon γ and nitric oxide synthase 2 in mouse macrophages
and during Salmonella enterica serovar typhimurium infection, J. Infect. Dis. 207
(2013) 1556–1568.
[26] F. Zhou, Molecular mechanisms of IFN-gamma to upregulate MHC class I antigen
processing and presentation, Int. Rev. Immunol. 28 (2009) 239–260.
[27] J.F. Curtin, M. Donovan, T.G. Cotter, Regulation and measurement of oxidative stress
in apoptosis, J. Immunol. Methods 265 (2002) 49–72.
[28] A.F. Valledor, E. Sánchez-Tilló, L. Arpa, J.M. Park, C. Caelles, J. Lloberas, A. Celada, Se-
lective roles of MAPKs during the macrophage response to IFN-gamma, J. Immunol.
180 (2008) 4523–4529.
[29] A.R. Seminara, P.P. Ruvolo, F. Murad, LPS/IFNgamma-induced RAW 264.7 apoptosis
is regulated by both nitric oxide-dependent and -independent pathways involving
JNK and the Bcl-2 family, Cell Cycle 6 (2007) 1772–1778.[30] S.E. Street, J.A. Trapani, D. MacGregor, M.J. Smyth, Suppression of lymphoma and ep-
ithelial malignancies effected by interferonγ, J. Exp. Med. 196 (2002) 129–134.
[31] H.A. Young, J.H. Bream, IFN-γ: recent advances in understanding regulation of ex-
pression, biological functions, and clinical applications, Curr. Top. Microbiol.
Immunol. 316 (2007) 97–117.
[32] V. Shankaran, H. Ikeda, A.T. Bruce, J.M. White, P.E. Swanson, L.J. Old, R.D. Schreiber,
IFN-γ and lymphocytes prevent primary tumour development and shape tumour
immunogenicity, Nature 410 (2001) 1107–1111.
[33] G.P. Dunn, C.M. Koebel, R.D. Schreiber, Interferons, immunity and cancer
immunoediting, Nat. Rev. Immunol. 6 (2006) 836–848.
[34] H.J. Chae, K.C. Ha, D.S. Kim, G.S. Cheung, Y.G. Kwak, H.M. Kim, Y.M. Kim, H.O. Pae, H.
T. Chung, S.W. Chae, H.R. Kim, Catalase protects cardiomyocytes via its inhibition of
nitric oxide synthesis, Nitric Oxide 14 (2006) 189–199.
[35] U. Rauen, T. Li, I. Ioannidis, H. de Groot, Nitric oxide increases toxicity of hydrogen
peroxide against rat liver endothelial cells and hepatocytes by inhibition of hydro-
gen peroxide degradation, Am. J. Physiol. Cell Physiol. 292 (2007) C1440–C1449.
[36] A.J. Burke, F.J. Sullivan, F.J. Giles, S.A. Glynn, The yin and yang of nitric oxide in cancer
progression, Carcinogenesis 34 (2013) 503–512.
[37] C.J. Horras, C.L. Lamb, K.A. Mitchell, Regulation of hepatocyte fate by interferon-γ,
Cytokine Growth Factor Rev. 22 (2011) 35–43.
[38] S.Heigold, C. Sers,W. Bechtel, B. Ivanovas, R. Schäfer, G. Bauer, Nitric oxidemediates ap-
optosis induction selectively in transformed ﬁbroblasts compared to nontransformed
ﬁbroblasts, Carcinogenesis 23 (2002) 929–941.
[39] M.A. Packer, M.P. Murphy, Peroxynitrite formed by simultaneous nitric oxide and
superoxide generation causes cyclosporin-A-sensitive mitochondrial calcium efﬂux
and depolarisation, Eur. J. Biochem. 234 (1995) 231–239.
[40] J. Genius, J. Fandrey, Nitric oxide affects the production of reactive oxygen species in
hepatoma cells: implications for the process of oxygen sensing, Free Radic. Biol.
Med. 29 (2000) 515–521.
[41] F. Wu, K. Tyml, J.X. Wilson, iNOS expression requires NADPH oxidase-dependent
redox signaling inmicrovascular endothelial cells, J. Cell. Physiol. 217 (2008) 207–214.
[42] P. Sestili, E. Clementi, A. Guidarelli, C. Sciorati, O. Cantoni, Endogenous and exogenous
nitric oxide enhance the DNA strand scission induced by tert-butylhydroperoxide in
PC12 cells via peroxynitrite-dependent and independent mechanisms, respectively,
Eur. J. Neurosci. 12 (2000) 145–154.
[43] L. Palomba, P. Sestili, O. Cantoni, tert-Butylhydroperoxide induces peroxynitrite-
dependent mitochondrial permeability transition leading PC12 cells to necrosis, J.
Neurosci. Res. 65 (2001) 387–395.
[44] C. Szabó, H. Ischiropoulos, R. Radi, Peroxynitrite: biochemistry, pathophysiology and
development of therapeutics, Nat. Rev. Drug Discov. 6 (2007) 662–680.
[45] P. Calcerrada, G. Peluffo, R. Radi, Nitric oxide-derived oxidants with a focus on
peroxynitrite: molecular targets, cellular responses and therapeutic implications,
Curr. Pharm. Des. 17 (2011) 3905–3932.
[46] P. Pacher, J.S. Beckman, L. Liaudet, Nitric oxide and peroxynitrite in health and dis-
ease, Physiol. Rev. 87 (2007) 315–424.
[47] U. Forstermann, T. Munzel, Endothelial NO synthase in vascular disease: from mar-
vel to menace, Circulation 113 (2006) 1708–1714.
[48] W.H. Kim, J.W. Lee, B. Gao, M.H. Jung, Synergistic activation of JNK/SAPK induced by
TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS
pathway, Cell. Signal. 17 (2005) 1516–1532.
[49] M. Deobagkar-Lele, E.S. Victor, D. Nandi, c-Jun NH2-terminal kinase is a critical node
in the death of CD4+ CD8+ thymocytes during Salmonella enterica serovar
Typhimurium infection, Eur. J. Immunol. 44 (2014) 137–149.
[50] R. González, G. Ferrín, P. Aguilar-Melero, I. Ranchal, C.I. Linares, R.I. Bello, M. De la
Mata, V. Gogvadze, J.A. Bárcena, J.M. Alamo, S. Orrenius, F.J. Padillo, B. Zhivotovsky,
J. Muntané, Targeting hepatoma using nitric oxide donor strategies, Antioxid.
Redox Signal. 18 (2013) 491–506.
